Jennifer Dumont

5.0k total citations
65 papers, 3.2k citations indexed

About

Jennifer Dumont is a scholar working on Molecular Biology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jennifer Dumont has authored 65 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 33 papers in Hematology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jennifer Dumont's work include Hemophilia Treatment and Research (30 papers), Platelet Disorders and Treatments (16 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Jennifer Dumont is often cited by papers focused on Hemophilia Treatment and Research (30 papers), Platelet Disorders and Treatments (16 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Jennifer Dumont collaborates with scholars based in United States, France and Canada. Jennifer Dumont's co-authors include Alan J. Bitonti, Robert Peters, Wayne I. Lencer, Richard S. Blumberg, Baisong Mei, Rashmi Kshirsagar, Susan C. Low, Scott Estes, Glenn F. Pierce and Gerburg M. Spiekermann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Jennifer Dumont

60 papers receiving 3.1k citations

Peers

Countries citing papers authored by Jennifer Dumont

Since Specialization

Citations

This map shows the geographic impact of Jennifer Dumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Dumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Dumont more than expected).

Fields of papers citing papers by Jennifer Dumont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Dumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Dumont. The network helps show where Jennifer Dumont may publish in the future.

Co-authorship network of co-authors of Jennifer Dumont

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Dumont. A scholar is included among the top collaborators of Jennifer Dumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Dumont. Jennifer Dumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unmet Needs, Factor Consumption, and Healthcare Resource Use Among People with Hemophilia a: Real-World Analysis of the Adelphi Hemophilia Disease Specific ProgrammeTM 2024 ·Blood ·Lynn Malec, Davide Matino, (unknown), (unknown), (unknown), (unknown), (unknown), Jennifer Dumont	0
2	Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study 2023 ·Blood ·Lynn Malec, An Van Damme, Anthony K.C. Chan, Mariya Spasova, Nisha Jain, (unknown), Jennifer Dumont, Stefan Lethagen, Manuel Carção, Flora Peyvandi	9
3	Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B 2023 ·Blood Advances ·Amy D. Shapiro, Roshni Kulkarni, Margaret V. Ragni, Hérvè Chambost, Johnny Mahlangu, (unknown), Beatrice Nolan, Margareth C. Ozelo, Meredith C. Foster, Annemieke Willemze, (unknown), Nisha Jain, Bent Winding, Jennifer Dumont, Stefan Lethagen, Chris Barnes, John Pasi	4
4	OC 69.5 Outcomes in Adult and Adolescent Patients with Severe Hemophilia a in the Phase 3 XTEND-1 Study Who Switched to Efanesoctocog Alfa Prophylaxis from an Observational Study with Factor VIII Prophylaxis 2023 ·Research and Practice in Thrombosis and Haemostasis ·Sophie Susen, Roshni Kulkarni, Keiji Nogami, Flora Peyvandi, Barbara A. Konkle, Elena Santagostino, Usman Khan, Annemieke Willemze, (unknown), Jennifer Dumont, Pratima Chowdary	1
5	Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults 2023 ·Research and Practice in Thrombosis and Haemostasis ·Barbara A. Konkle, Johannes Oldenburg, John Pasi, Roshni Kulkarni, Beatrice Nolan, Johnny Mahlangu, Guy Young, Simon Brown, Ingrid Pabinger, Amy D. Shapiro, Claude Négrier, Victor S. Blanchette, Margaret V. Ragni, Jennifer Dumont, Stefan Lethagen	6
6	The Yin-Yang of the Green Fluorescent Protein: Impact on Saccharomyces cerevisiae stress resistance 2022 ·Journal of Photochemistry and Photobiology B Biology ·(unknown), (unknown), Jennifer Dumont, (unknown), (unknown), (unknown), (unknown), Walid Horrigue, (unknown), (unknown), (unknown), (unknown), (unknown), Sébastien Dupont, Laurent Beney, Hazel M. Davey, Stéphane Guyot	0
7	Increased xerotolerance of Saccharomyces cerevisiae during an osmotic pressure ramp over several generations 2021 ·Microbial Biotechnology ·Stéphane Guyot, Laurence Pottier, (unknown), Jennifer Dumont, (unknown), Sébastien Dupont, (unknown), (unknown), (unknown), John E. Hallsworth, Laurent Beney, Patrick Gervais	9
8	Microbial transfers from permanent grassland ecosystems to milk in dairy farms in the Comté cheese area 2021 ·Scientific Reports ·Nicolas Chemidlin Prévost‐Bouré, Battle Karimi, Sophie Sadet-Bourgeteau, Christophe Djemiel, (unknown), Jennifer Dumont, (unknown), Virginie Nowak, (unknown), (unknown), (unknown), François Gillet, Yvette Bouton	10
9	Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor 2020 ·Frontiers in Immunology ·(unknown), Paul Moorehead, Tongyao Liu, Jennifer Dumont, David W. Scott, Christine Hough, David Lillicrap	7
10	Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein 2017 ·Haemophilia ·Johannes Oldenburg, Roshni Kulkarni, Alok Srivastava, Johnny Mahlangu, Victor S. Blanchette, Elisa Tsao, Bent Winding, Jennifer Dumont, Nisha Jain	38
11	Extravascular Distribution of Conventional and Ehl FIX Products Using In Vivo SPECT Imaging Analysis in Hemophilia B Mice 2017 ·Blood ·(unknown), Arjan van der Flier, (unknown), Jennifer Dumont, Kelly Davis Orcutt, Apollina Goel, Robert Peters	4
12	Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion protein 2015 ·Biologicals ·Justin T. McCue, Rashmi Kshirsagar, (unknown), Qi Lü, Mingxuan Zhang, Baisong Mei, Robert Peters, Glenn F. Pierce, Jennifer Dumont, Stephen W. Raso, (unknown)	31
13	Evaluation of the toxicology, pharmacokinetics, and local tolerance of recombinant factor IX Fc fusion protein in animals 2015 ·Thrombosis Research ·Jennifer Dumont, Kenneth S. Loveday, David R. Light, Glenn F. Pierce, Haiyan Jiang	6
14	Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients 2012 ·Blood ·Jerry S. Powell, Neil C. Josephson, Doris Quon, Margaret V. Ragni, Gregory Cheng, (unknown), Haiyan Jiang, Lian Li, Jennifer Dumont, Jaya Goyal, Xin Zhang, Jürg M. Sommer, Justin T. McCue, (unknown), Alvin Luk, Glenn F. Pierce	171
15	Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs 2012 ·Blood ·Jennifer Dumont, Tongyao Liu, Susan C. Low, Xin Zhang, George D. Kamphaus, Paul Sakorafas, (unknown), Douglas Drager, Thomas J. Reidy, Justin T. McCue, (unknown), Elizabeth P. Merricks, Timothy C. Nichols, Alan J. Bitonti, Glenn F. Pierce, Haiyan Jiang	115
16	Effects of ozone on stomatal responses to environmental parameters (blue light, red light, CO2 and vapour pressure deficit) in three Populus deltoides × Populus nigra genotypes 2012 ·Environmental Pollution ·Jennifer Dumont, Fabien Spicher, Pierre Montpied, Pierre Dizengremel, Yves Jolivet, Didier Le Thiec	43
17	Delivery of an Erythropoietin-Fc Fusion Protein by Inhalation in Humans through an Immunoglobulin Transport Pathway 2005 ·Journal of Aerosol Medicine ·Jennifer Dumont, Alan J. Bitonti, (unknown), (unknown), (unknown), Stephen P. Newman	98
18	Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domain 1996 ·The Journal of Steroid Biochemistry and Molecular Biology ·Alan J. Bitonti, Jennifer Dumont, Francesco G. Salituro, Ian A. McDonald, Esa T. Jarvi, (unknown), Paul S. Wright, (unknown)	3
19	Polyamine analogs with antitumor activity 1990 ·Journal of Medicinal Chemistry ·Mark L. Edwards, (unknown), David M. Stemerick, (unknown), (unknown), Gregory F. Davis, Jennifer Dumont, Philippe Bey	52
20	Uptake of antimalarial bis(benzyl)polyamine analogs by human erythrocytes 1989 ·Biochemical Pharmacology ·Alan J. Bitonti, Jennifer Dumont, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact